tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ravi Misra, 9 are a BUY (34.62%), 15 are a HOLD (57.69%), 2 are a SELL (7.69%).
Analyst Ravi Misra, currently employed at TRUIST, carries an average stock price target met ratio of 60.61% that have a potential upside of 15.38% achieved within 87 days.
Ravi Misra’s has documented 51 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IART, Integra LifeSciences Holdings at 14-Oct-2026.
Analyst best performing recommendations are on NNOX (NANO X IMAGING LTD).
The best stock recommendation documented was for IART (INTEGRA LIFESCIENCES HOLDINGS) at 7/16/2026. The price target of $19 was fulfilled within 4 days with a profit of $0.85 (4.28%) receiving and performance score of 10.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Mar-2025
$200
$45.49 (29.44%)
$200
Buy Since 01-May-2025
$205
$50.49 (32.68%)
$235
Buy Since 18-Oct-2017
$162
$7.49 (4.85%)
$250
9 days ago
(15-Oct-2026)
20/30 (66.67%)
$12.66 (8.48%)
101
Buy Since 17-Oct-2025
$215
$60.49 (39.15%)
$172
10 days ago
(14-Oct-2026)
3/5 (60%)
$70.56 (48.85%)
40
Buy Since 18-Oct-2013
$175
$20.49 (13.26%)
$210
15 days ago
(09-Oct-2026)
46/73 (63.01%)
$32.29 (22.63%)
145
Which stock is Ravi Misra most bullish on?
Which stock is Ravi Misra most reserved on?
What Year was the first public recommendation made by Ravi Misra?
